SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study

Héctor Eloy Tamez-Perez, Enrique Delgadillo-Esteban, David Soni-Duque, Mayra Ivonne Hernández-Coria, Alejandra Lorena Tamez-Peña

Resultado de la investigación

8 Citas (Scopus)

Resumen

This paper investigates the interpretation of unbounded (scalar) adjective antonyms with and without negation such as (not) narrow – (not) wide and bounded adjective antonyms with and without negation such as (not) dead – (not) alive as well as their interpretations with approximating degree modifiers, fairly and almost, respectively. The investigation was designed to test the boundedness hypothesis, namely that the negator is sensitive to the configuration of the adjective in terms of boundedness. The data are Swedish and the results of the experiments show that negated unbounded adjectives do not evoke the interpretation of their antonyms, i.e. not wide does not equal ‘narrow’. The results of the experiments with bounded adjectives with and without negation showed that some of the negated adjectives were interpreted as synonyms of their antonyms, i.e. not alive equals ‘dead’. However, this pattern was not consistent across the bounded adjectives, since a number of them readily lent themselves to partial readings. Four types of bounded antonyms emerged from the participants’ judgements. For both unbounded and bounded adjectives, the interpretations of the approximating degree modifiers and the adjectives were not significantly different from the negated adjectives.
Idioma originalEnglish
Título de la publicación alojadaJournal of Diabetes and Metabolic Disorders
EditorialBioMed Central Ltd.
ISBN (versión impresa)2251-6581
DOI
EstadoPublished - 30 jun 2017
Publicado de forma externa

Serie de la publicación

NombreJournal of Diabetes and Metabolic Disorders
Volumen16

Huella Profundice en los temas de investigación de 'SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study'. En conjunto forman una huella única.

  • Citar esto

    Tamez-Perez, H. E., Delgadillo-Esteban, E., Soni-Duque, D., Hernández-Coria, M. I., & Tamez-Peña, A. L. (2017). SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study. En Journal of Diabetes and Metabolic Disorders (Journal of Diabetes and Metabolic Disorders; Vol. 16). BioMed Central Ltd.. https://doi.org/10.1186/s40200-017-0308-4